Hims & Hers Update
We have defined a new Fibonacci retracement zone for potential new acquisitions. Hims & Hers has successfully completed its long-term
Read analysis
Elliott Wave Analyses
Health & Biotech
From pharmaceutical giants and health insurers to cutting-edge biotech and gene-editing pioneers — this sector tracks the companies advancing human health and medicine.
Canopy Growth (CGC) Update
Canopy Growth Activates Our Anticipated Fibonacci Retracement Zone On March 17, 2026, we published our Elliott Wave analysis for Canopy
Read analysis
Canopy Growth (CGC) EW-Analysis
Canopy Growth — Has the Historical Bottom Been Reached? Since its IPO, Canopy Growth experienced a massive bull run, reaching an
Read analysis
Hims & Hers Health Update
We can now successfully deactivate our anticipated Fibonacci retracement zone. This chart shows our analysis from March 3rd, 2026, where
Read analysis
Tilray brands (TLRY) EW-Analysis
Since its IPO in July 2018, Tilray Brands reached an all-time high of $3,000 before entering a prolonged corrective
Read analysis
Merck KGaA (MRK) EW-Analysis
Where is the end of this correction? Since 2002, Merck has shown a structurally clean price action. The formation of
Read analysisWant to follow the latest analyses?
Join free to explore Elliott Wave breakdowns and the public performance tracker.